# EDGAR Filing Document

**Accession Number:** 0001959708
**File Stem:** 9999999994-23-000101
**Filing Date:** 2023-3
**Character Count:** 1246
**Document Hash:** 5f0a152fe4d54d44bcb40862097f022c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**9999999994-23-000101.hdr.sgml**: 20230309

**ACCESSION NUMBER**: 9999999994-23-000101

**CONFORMED SUBMISSION TYPE**: QUALIF

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230308

**DATE AS OF CHANGE**: 20230309

**EFFECTIVENESS DATE**: 20230308

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Algernon Neuroscience Inc.
- **CENTRAL INDEX KEY:** 0001959708
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **IRS NUMBER:** 785435413
- **STATE OF INCORPORATION:** A1
- **FISCAL YEAR END:** 0831

**FILING VALUES:**
- **FORM TYPE:** QUALIF
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 024-12117
- **FILM NUMBER:** 23718040

**BUSINESS ADDRESS:**
- **STREET 1:** 400-601 WEST BROADWAY
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V5Z 4C2
- **BUSINESS PHONE:** (604) 398-4175

**MAIL ADDRESS:**
- **STREET 1:** 400-601 WEST BROADWAY
- **CITY:** VANCOUVER
- **STATE:** A1
- **ZIP:** V5Z 4C2

### UNITED STATES
### SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## Notice of Qualification

**Date:** March 8, 2023

**Time:** 16:00:00

**Form Type:** 1-A

---

**CIK:** 0001959708

**Company Name:** Algernon Neuroscience Inc.

**File Number:** 024-12117